Industry NewsKRASG12C inhibitor sotorasib may offer long-term clinical benefit in patients with non-small cell lung cancer
Industry NewsPeople in deprivation with poorer lifestyle factors at most risk for severe illness or death with COVID-19
Industry NewsMaze Therapeutics announces Phase 1 trial initiation evaluating MZE001 as a potential oral treatment for Pompe Disease
Industry NewsImmutep granted Australian patent for Eftilagimod Alpha in combination with a PD-1 pathway inhibitor
Industry NewsNanoparticle-formulated drug combination is effective in medulloblastoma, a pediatric brain tumor